Spots Global Cancer Trial Database for mor03087 (mor202)
Every month we try and update this database with for mor03087 (mor202) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Phase 1/2a Study of Human Anti-CD 38 Antibody MOR03087 (MOR202) in Relapsed/Refractory Multiple Myeloma | NCT01421186 | Multiple Myelom... | MOR03087 phase ... MOR03087 Dexamethasone Pomalidomide Lenalidomide | 18 Years - | MorphoSys AG | |
A Phase 1/2a Study of Human Anti-CD 38 Antibody MOR03087 (MOR202) in Relapsed/Refractory Multiple Myeloma | NCT01421186 | Multiple Myelom... | MOR03087 phase ... MOR03087 Dexamethasone Pomalidomide Lenalidomide | 18 Years - | MorphoSys AG |